Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP, was quoted in a September 25 article in The Inverse which discusses the findings of a new study out of Stanford University which estimates that 9.3 percent of the US population has coronavirus antibodies. Based on a survey of 28,503 people who were receiving dialysis treatment, the study reports that eight percent of those surveyed tested positive for coronavirus antibodies. While dialysis patients may not be a perfect representation of the US population, Dr. El-Sadr commented that these estimates still provide a useful overview and went on to say:
“[Seroprevalence, or the level of a pathogen in a population,] data thus far in the US have always had their limitations,” El-Sadr tells Inverse. “They made a good effort…so that it could be as representative as possible.”
